CERENOME, INC.

PSTV

CERENOME, INC.

PSTV

Insider Sentiment (TTM):

Last Purchase:2025-11-04Last Sale:2023-11-20Shares Purchased (TTM):20,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:9,123,040Shares Outstanding:6,646,049Institutional Ownership Pct.:137.27%

Earnings Market Reaction:

Filing Date:2026-05-15Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	2	3	4	13	2	10	0	1	5	3	9	11
Restricted Cash And Cash Equivalents At Carrying V…	-	-	5	-	-	-	-	-	-	-	-	-
Short Term Investments	6	12	4	3	5	-	4	4	4	0	-	-
Grants Receivable Current	2	1	0	-	1	-	1	-	-	-	-	0
Other Assets Current	1	2	2	1	1	1	1	1	1	1	1	0
Assets Current	12	18	15	18	9	11	5	5	9	4	10	12
Property Plant And Equipment Net	1	1	0	0	0	0	0	1	1	1	1	1
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0
Other Intangible Assets Net	0	0	0	0	0	0	0	1	1	0	0	0
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	14	20	16	19	10	12	7	7	11	6	11	13
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	8	6	6	12	6	9	11	8	7	6	7	6
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Income Current	1	1	1	2	1	1	1	1	2	0	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	4	4	4
Lines Of Credit Current	0	1	1	-	-	-	3	3	3	-	-	-
Other Liabilities Current	0	0	0	-	-	-	-	-	-	-	-	-
Liabilities Current	9	8	12	14	7	11	16	12	19	10	11	11
Operating Lease Liability Noncurrent	-	-	0	-	-	-	0	0	0	0	0	0
Deferred Income Noncurrent	-	-	-	-	-	-	-	-	-	-	2	-
Liabilities	9	8	12	14	7	36	16	12	19	10	13	11
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Treasury Stock Common Value	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-0	-
Additional Paid In Capital	538	535	520	516	509	488	485	485	480	479	479	479
Retained Earnings Accumulated Deficit	-532	-523	-516	-510	-506	-511	-493	-490	-487	-484	-481	-477
Stockholders Equity	5	12	4	5	3	-24	-9	-5	-8	-5	-1	3
Liabilities And Stockholders Equity	14	20	16	19	10	12	7	7	11	6	11	13
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	2,000	2,000	2,000	2,000	2,000	100	100	100	100	100	100	100
Common Stock Shares Issued	7	7	6	5	4	1	0	0	0	0	0	0
Shares Outstanding	7	7	6	5	4	1	0	0	0	0	0	0
Treasury Stock Common Shares	0	0	0	0	0	0	0	0	0	0	0	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	3.05%	-24.19%	-	-	-	-	-	-	-	-	-	-
2025	-32.38%	29.49%	118.86%	-9.37%	34.86%	0.15%	0.51%	7.26%	-45.70%	-51.68%	-17.34%	-21.00%
2024	1.29%	-33.19%	-25.43%	-0.70%	-8.45%	-4.93%	10.32%	-2.38%	-1.59%	-17.07%	-68.53%	-79.58%
2023	-	-	-	-44.80%	-52.00%	-36.00%	33.61%	56.56%	76.23%	-17.20%	-22.48%	-1.83%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.37	2.27	1.23	1.29	1.26	1.03	0.34	0.44	0.50	0.41	0.92	1.10
Quick Ratio	1.37	2.27	1.23	1.29	1.26	1.03	0.34	0.44	0.50	0.41	0.92	1.10
Working Capital	3.20M	10.07M	2.86M	3.97M	1.90M	309.00K	-10.29M	-6.75M	-9.41M	-6.19M	-893.00K	1.05M
Leverage & Debt
Debt to Equity	1.57	0.67	3.09	2.69	2.41	-1.51	-1.74	-2.35	-2.47	-2.16	-9.45	4.06
Interest Coverage TTM	-46.32	-33.42	-13.96	-11.08	-17.57	-19.80	-61.23	-79.64	-67.17	-40.33	-33.72	-30.56
Debt Ratio	0.61	0.40	0.76	0.73	0.71	2.96	2.35	1.74	1.68	1.86	1.12	0.80
Efficiency & Turnover
Asset Turnover TTM	0.34	0.32	0.45	0.41	0.49	0.59	0.65	0.57	0.43	0.57	0.28	0.21
Per Share Metrics
Diluted EPS TTM	-3.78	-1.80	-7.19	-4.79	-2.27	-46.54	-42.13	-41.00	-30.79	-68.10	-105.99	-117.54
Free Cash Flow Per Share TTM	-3.41	-3.27	-6.70	-3.67	-8.73	-21.15	-40.28	-36.28	-38.90	-67.53	-103.56	-103.26
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	-	-	-	103.81%	104.85%	108.04%	113.12%
Operating Profit Margin TTM	-628.12%	-364.36%	-293.46%	-255.91%	-240.23%	-286.82%	-252.32%	-255.95%	-256.04%	-195.56%	-271.14%	-400.83%
Net Profit Margin TTM	-620.70%	-230.24%	-429.43%	-391.33%	-357.85%	-520.90%	-222.84%	-225.07%	-240.15%	-193.49%	-271.04%	-404.27%
Growth Metrics
Net Revenue Growth (1Y)	-20.95%	-0.46%	-10.49%	-8.16%	-3.49%	-14.43%	18.54%	52.63%	113.20%	733.42%	2,093.30%	5,038.36%
Net Income Growth (1Y)	37.11%	-56.00%	72.49%	59.69%	43.82%	130.36%	-2.54%	-15.03%	-22.92%	-43.85%	-34.32%	-19.22%
EPS Growth (1Y)	-61.53%	-96.14%	-85.28%	-88.32%	-80.68%	-31.66%	-53.90%	-65.11%	-70.25%	-69.86%	-63.40%	-54.18%
Calculated Values
Free Cash Flow TTM	-23.55M	-21.72M	-20.84M	-15.78M	-16.90M	-12.32M	-10.70M	-11.40M	-10.12M	-11.67M	-13.01M	-13.32M
Net Debt	-2.37M	-2.36M	-3.51M	-13.29M	-2.23M	-9.87M	3.22M	2.07M	-1.62M	689.00K	-4.58M	-6.66M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-11-04Purchase

Owner: Sims, Andrew John Hugh Ma…

Title: Chief Financial Officer

Shares: 20,000

Price/Share: $0.51

Value: $10,200.00

Shares Owned: 68,138

Relationship: Officer

Ownership: Direct

2025-08-22Purchase

Owner: Lenk, Robert P

Title: -

Shares: 110,000

Price/Share: $0.49

Value: $53,900.00

Shares Owned: 139,327

Relationship: Director

Ownership: Direct

2024-09-13Purchase

Owner: Hawkins, Richard J

Title: -

Shares: 4,000

Price/Share: $1.50

Value: $6,000.00

Shares Owned: 15,188

Relationship: Director

Ownership: Direct

2024-09-12Purchase

Owner: Hawkins, Richard J

Title: -

Shares: 6,285

Price/Share: $1.35

Value: $8,484.75

Shares Owned: 11,188

Relationship: Director

Ownership: Direct

2024-09-11Purchase

Owner: Petersen, Greg

Title: -

Shares: 12,500

Price/Share: $1.35

Value: $16,875.00

Shares Owned: 48,921

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-11-04	Sims, Andrew John Hugh Ma…	Officer	Chief Financial Officer	Direct	Purchase	20,000	0.51	$10,200.00	68,138	4
2025-08-22	Lenk, Robert P	Director	-	Direct	Purchase	110,000	0.49	$53,900.00	139,327	4
2024-09-13	Hawkins, Richard J	Director	-	Direct	Purchase	4,000	1.50	$6,000.00	15,188	4
2024-09-12	Hawkins, Richard J	Director	-	Direct	Purchase	6,285	1.35	$8,484.75	11,188	4
2024-09-11	Petersen, Greg	Director	-	Direct	Purchase	12,500	1.35	$16,875.00	48,921	4
2024-09-11	Clowes, Howard	Director	-	Direct	Purchase	5,000	1.34	$6,700.00	26,497	4
2024-09-10	Sims, Andrew John Hugh Ma…	Officer	Chief Financial Officer	Direct	Purchase	4,098	1.27	$5,204.46	9,815	4
2024-09-10	Hedrick, Marc H	Director,Officer	Chief Executive Officer	Direct	Purchase	8,000	1.23	$9,840.00	20,425	4
2024-05-08	Clowes, Howard	Director	-	Direct	Purchase	9,804	2.04	$20,000.16	21,497	4
2024-05-08	Sims, Andrew John Hugh Ma…	Officer	Chief Financial Officer	Direct	Purchase	4,902	2.04	$10,000.08	5,717	4
2024-05-08	Petersen, Greg	Director	-	Direct	Purchase	12,255	2.04	$25,000.20	36,421	4
2024-05-08	Hawkins, Richard J	Director	-	Direct	Purchase	4,902	2.04	$10,000.08	4,903	4
2024-05-08	Lenk, Robert P	Director	-	Direct	Purchase	4,167	2.04	$8,500.68	29,327	4
2024-05-08	Hedrick, Marc H	Director,Officer	Chief Executive Officer	Direct	Purchase	12,255	2.04	$25,000.20	12,425	4
2023-11-20	Hedrick, Marc H	Director,Officer	Chief Executive Officer	Direct	Sale	2,068	1.96	$4,053.28	170	4
2023-11-16	Lenk, Robert P	Director	-	Direct	Purchase	1,000	1.95	$1,950.00	25,160	4
2023-11-13	Lenk, Robert P	Director	-	Direct	Purchase	4,000	1.43	$5,720.00	23,160	4
2023-11-09	Lenk, Robert P	Director	-	Direct	Purchase	4,199	1.59	$6,676.41	17,160	4
2023-11-07	Lenk, Robert P	Director	-	Direct	Purchase	6,000	1.64	$9,840.00	7,961	4
2023-09-13	Clowes, Howard	Director	-	Direct	Purchase	6,993	1.43	$9,999.99	11,693	4
2023-09-11	Petersen, Greg	Director	-	Direct	Purchase	20,000	1.70	$34,000.00	24,166	4
2023-06-06	Clowes, Howard	Director	-	Direct	Purchase	1,000	3.98	$3,980.00	4,700	4
2023-05-03	Clowes, Howard	Director	-	Direct	Purchase	2,500	3.64	$9,100.00	3,700	4
2023-03-03	Hawkins, Richard J	Director	-	Direct	Purchase	1	1000.00	$1,000.00	1	4
2022-12-30	Lenk, Robert P	Director	-	Direct	Sale	1,500	0.31	$465.00	8,500	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

137.27%

Inst. Shares: 9,123,040

Shares Outstanding: 6,646,049

2025-12-31

Inst. Shares: 11,044,012

Shares Outstanding: 3,112,184

2025-09-30

121.11%

Inst. Shares: 5,204,341

Shares Outstanding: 4,297,159

2025-06-30

19.53%

Inst. Shares: 378,108

Shares Outstanding: 1,935,554

2025-03-31

42.25%

Inst. Shares: 246,168

Shares Outstanding: 582,668

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	9,123,040	6,646,049	137.27%
2025-12-31	11,044,012	3,112,184	-
2025-09-30	5,204,341	4,297,159	121.11%
2025-06-30	378,108	1,935,554	19.53%
2025-03-31	246,168	582,668	42.25%
2024-12-31	678,173	265,610	255.33%
2024-09-30	671,584	314,231	213.72%
2024-06-30	681,594	260,033	262.12%
2024-03-31	83,589	172,869	48.35%
2023-12-31	106,958	125,637	85.13%
2023-09-30	76,796	129,014	59.53%
2023-06-30	101,711	100,375	101.33%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

CERENOME, INC. (PSTV) — SEC Financial Statements & Analysis

CERENOME, INC. (PSTV) is a surgical & medical instruments & apparatus company, incorporated in DE. CERENOME, INC. trades on Nasdaq as: PSTV. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), CERENOME, INC. reported a -20.95% year-over-year revenue growth, a Gross Profit Margin of 103.81% (TTM), a Debt-to-Equity ratio of 1.57x. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -20.95%
Gross Profit Margin TTM: 103.81%
Debt To Equity: 1.57x

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CERENOME, INC. in?

CERENOME, INC. (PSTV) operates in the Surgical & Medical Instruments & Apparatus industry.

What exchange does PSTV trade on?

CERENOME, INC. (PSTV) trades on the Nasdaq.

Where is CERENOME, INC. incorporated?

CERENOME, INC. is incorporated in DE.

CERENOME, INC.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

CERENOME, INC. (PSTV) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.
Main Street's price.

CERENOME, INC. (PSTV) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Surgical & Medical Instruments & Apparatus

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.